
NanoVibronix, Inc. Common Stock
NAOV
NAOV: NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
moreShow NAOV Financials
Recent trades of NAOV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NAOV's directors and management
Government lobbying spending instances
-
$5,000 Jul 14, 2021 Issue: Health Issues
-
$15,000 Apr 22, 2021 Issue: Health Issues
-
$30,000 Jan 11, 2021 Issue: Health Issues
New patents grants
-
Patent Title: System and method for surface acoustic wave treatment of skin Mar. 07, 2017
-
Patent Title: System and method for surface acoustic wave treatment of medical devices May. 12, 2015
Federal grants, loans, and purchases
Followers on NAOV's company Twitter account
Number of mentions of NAOV in WallStreetBets Daily Discussion
Recent insights relating to NAOV
Recent picks made for NAOV stock on CNBC
ETFs with the largest estimated holdings in NAOV
Flights by private jets registered to NAOV